Inspire Investing LLC Trims Stock Position in Maximus, Inc. (NYSE:MMS)

Inspire Investing LLC reduced its holdings in Maximus, Inc. (NYSE:MMS) by 3.1% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,112 shares of the health services provider’s stock after selling 131 shares during the quarter. Inspire Investing LLC’s holdings in Maximus were worth $352,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Rise Advisors LLC increased its position in shares of Maximus by 1,445.0% in the first quarter. Rise Advisors LLC now owns 309 shares of the health services provider’s stock worth $26,000 after purchasing an additional 289 shares during the last quarter. GAMMA Investing LLC grew its stake in Maximus by 224.5% in the 2nd quarter. GAMMA Investing LLC now owns 344 shares of the health services provider’s stock worth $29,000 after buying an additional 238 shares in the last quarter. Blue Trust Inc. grew its stake in Maximus by 201.5% in the 2nd quarter. Blue Trust Inc. now owns 392 shares of the health services provider’s stock worth $33,000 after buying an additional 262 shares in the last quarter. Kapitalo Investimentos Ltda bought a new position in shares of Maximus in the 4th quarter worth $52,000. Finally, Archer Investment Corp raised its position in shares of Maximus by 8,788.9% during the 2nd quarter. Archer Investment Corp now owns 800 shares of the health services provider’s stock valued at $69,000 after buying an additional 791 shares in the last quarter. Institutional investors own 97.21% of the company’s stock.

Maximus Stock Down 0.6 %

Shares of NYSE:MMS opened at $89.98 on Monday. The firm has a market capitalization of $5.47 billion, a PE ratio of 23.62 and a beta of 0.76. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.59 and a current ratio of 1.59. Maximus, Inc. has a 52-week low of $72.39 and a 52-week high of $93.97. The firm has a fifty day moving average of $89.80 and a 200 day moving average of $86.15.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Wednesday, August 7th. The health services provider reported $1.74 EPS for the quarter, topping the consensus estimate of $1.47 by $0.27. Maximus had a net margin of 5.59% and a return on equity of 20.91%. The firm had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.29 billion. During the same period last year, the firm posted $0.78 earnings per share. The business’s revenue was up 10.6% compared to the same quarter last year. As a group, research analysts anticipate that Maximus, Inc. will post 6.12 EPS for the current fiscal year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Saturday, August 31st. Stockholders of record on Thursday, August 15th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Thursday, August 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.33%. Maximus’s dividend payout ratio (DPR) is currently 31.50%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.